Moderna officer Stephen Hoge proposes $8.6M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Moderna, Inc. officer Stephen Hoge reported a proposed sale of 39,160 common shares, with an aggregate market value of $8,601,863.46, for approximately November 16, 2026. The notice says the shares were acquired from the issuer through a stock option exercise, with cash payment, on November 16, 2026. It lists June 15, 2026 as the plan adoption or instruction date if relying on Rule 10b5-1.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Stock Option Exercise financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Rule 10b5-1 date does Stephen Hoge's MRNA notice list?
What earlier MRNA sales by Stephen Hoge are listed in the notice?
AI-generated analysis. How Rhea-AI works. Not financial advice.